FY2025 · ended Dec 31, 2025 · Revenue $138.90M, +1.1% YoY · Filed Mar 2, 2026
Quanterix Corporation (QTRX) files with the SEC under industry code 3826, Laboratory Analytical Instruments. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $138.9 million and a net loss of $107.2 million. Free cash flow was -$79.8 million. As of Jun 30, 2026 it held $93.5 million in cash and investments and $33.4 million in total debt.
Revenue (TTM)
$153.41M
+22.0% vs year-ago TTM
Net income (TTM)
$-123.11M
-74.6% vs year-ago TTM
Operating cash flow (TTM)
$-80.92M
-173.4% vs year-ago TTM
Free cash flow (TTM)
$-81.68M
-148.4% vs year-ago TTM
EPS (TTM)
$-2.63
-44.4% vs year-ago TTM
Dividend per share
None
Shares outstanding
46.94M
+21.1% vs prior year
Net cash
$60.14M
as of Jun 30, 2026
Operating margin
-99.6%
FY 2026
Company profile
- Industry
- Laboratory Analytical Instruments (SIC 3826)
- Listed as
- QTRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Billerica, MA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1503274
Other Laboratory Analytical Instruments companies
- Agilent Technologies, Inc. A
- Waters Corp /DE/ WAT
- Illumina, Inc. ILMN
- Mettler Toledo International INC/ MTD
- Revvity, Inc. RVTY
- Avantor, Inc. AVTR
- Bio-Rad Laboratories, Inc. BIO
- Bruker Corp BRKR
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $138.9M | $137.4M | $122.4M | $105.5M | $110.6M |
| Operating income | -$125.5M | -$52.6M | -$46.0M | -$104.3M | -$56.5M |
| Net income | -$107.2M | -$38.5M | -$28.4M | -$99.6M | -$55.5M |
| Diluted EPS | -$2.51 | -$1.00 | -$0.75 | -$2.69 | -$1.54 |
| Operating cash flow | -$77.2M | -$35.2M | -$18.8M | -$48.6M | -$47.6M |
| Free cash flow | -$79.8M | -$38.5M | -$22.7M | -$60.2M | -$61.3M |
| Total assets | $418.8M | $406.5M | $428.6M | $433.6M | $501.5M |
| Total liabilities | $123.0M | $76.5M | $78.6M | $75.7M | $60.6M |
| Stockholders' equity | $295.7M | $330.0M | $350.0M | $357.9M | $442.8M |
| Cash and investments | $118.2M | $289.1M | $181.3M | $338.7M | $396.5M |
| Total debt | $37.2M | $37.4M | $41.5M | $44.1M | $21.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 10, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 9, 2026 | Jun 9, 2026 |
| 8-K |
Current report
Officer or director change
|
May 26, 2026 | May 14, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
May 12, 2026 | May 11, 2026 |
All 1000 Quanterix Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.